{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T12:37:58Z","timestamp":1771591078476,"version":"3.50.1"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,5]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>Subclinical hypothyroidism affects 4.3% of the US population. Despite this prevalence, whether to treat or to observe patients with subclinical hypothyroidism remains controversial. Guidelines for overt hypothyroidism strongly favor treatment for symptomatic benefits, but the same benefits of levothyroxine treatment have not been proven for patients with subclinical hypothyroidism\u2014most likely due to the asymptomatic nature of the condition. Additionally, a connection between subclinical hypothyroidism and cardiovascular complications has not been definitively established, although the evidence favors a relationship. This article describes the background, presentation, and diagnostics of subclinical hypothyroidism, treatment, and potential cardiovascular complications, so clinicians can decide if initiating treatment is best for their patients with subclinical hypothyroidism.<\/jats:p>","DOI":"10.1097\/01.jaa.0000660120.03250.55","type":"journal-article","created":{"date-parts":[[2020,4,10]],"date-time":"2020-04-10T21:08:50Z","timestamp":1586552930000},"page":"21-26","source":"Crossref","is-referenced-by-count":6,"title":["Subclinical hypothyroidism"],"prefix":"10.1097","volume":"33","author":[{"given":"Chelsea","family":"Simon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Weidman-Evans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Allen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230817","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4061\/2011\/809341","article-title":"Hypothyroidism and thyroid substitution: historical aspects","volume":"2011","author":"Lindholm","year":"2011","journal-title":"J Thyroid Res"},{"issue":"2","key":"R2-20230817","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.mcna.2012.01.005","article-title":"Hypothyroidism: etiology, diagnosis, and management","volume":"96","author":"Almandoz","year":"2012","journal-title":"Med Clin North Am"},{"key":"R3-20230817","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2147\/CIA.S23966","article-title":"Hypothyroidism in the elderly: diagnosis and management","volume":"7","author":"Bensenor","year":"2012","journal-title":"Clin Interv Aging"},{"issue":"1","key":"R4-20230817","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3803\/EnM.2014.29.1.20","article-title":"Prevalence and risk factors of subclinical thyroid disease","volume":"29","author":"Kim","year":"2014","journal-title":"Endocrinol Metab (Seoul)"},{"key":"R5-20230817","article-title":"Hypothyroidism","author":"Orlander"},{"issue":"6","key":"R6-20230817","doi-asserted-by":"crossref","first-page":"988","DOI":"10.4158\/EP12280.GL","article-title":"American Association of Clinical Endocrinologists and American Thyroid Association Taskforce on Hypothyroidism in Adults. Clinical practice guidelines for hypothyroidism in adults","volume":"18","author":"Garber","year":"2012","journal-title":"Endocr Pract"},{"issue":"10","key":"R8-20230817","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1089\/105072502761016458","article-title":"Epidemiology and prevention of clinical and subclinical hypothyroidism","volume":"12","author":"Vanderpump","year":"2002","journal-title":"Thyroid"},{"key":"R9-20230817","first-page":"1119","article-title":"Endocrine disorders","author":"Fitzgerald","year":"2018","journal-title":"Current Medical Diagnosis & Treatment"},{"key":"R10-20230817","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.etap.2017.05.002","article-title":"Associations between the levels of thyroid hormones and lipid\/lipoprotein levels: data from National Health and Nutrition Examination Survey 2007-2012","volume":"53","author":"Jain","year":"2017","journal-title":"Environ Toxicol Pharmacol"},{"issue":"suppl 2","key":"R11-20230817","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.4103\/2230-8210.83337","article-title":"Central hypothyroidism","volume":"15","author":"Gupta","year":"2011","journal-title":"Indian J Endocrinol Metab"},{"issue":"2","key":"R12-20230817","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1001\/jama.2019.9052","article-title":"Subclinical hypothyroidism: a review","volume":"322","author":"Biondi","year":"2019","journal-title":"JAMA"},{"issue":"6","key":"R13-20230817","doi-asserted-by":"crossref","first-page":"363","DOI":"10.14423\/SMJ.0000000000000823","article-title":"Effects of long-term combination LT4 and LT3 therapy for improving hypothyroidism and overall quality of life","volume":"111","author":"Tariq","year":"2018","journal-title":"South Med J"},{"key":"R14-20230817","article-title":"Subclinical hypothyroidism in nonpregnant adults","author":"Ross"},{"key":"R15-20230817","article-title":"Clinical manifestations of hypothyroidism","author":"Surks"},{"key":"R16-20230817","first-page":"43","article-title":"Signs and symptoms of thyroid dysfunction","author":"Karnath","year":"2006","journal-title":"Hosp Physician"},{"issue":"2","key":"R17-20230817","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s42000-018-0004-x","article-title":"Subclinical hypothyroidism: new trials, old caveats","volume":"17","author":"Lamine","year":"2018","journal-title":"Hormones (Athens)"},{"issue":"6","key":"R18-20230817","doi-asserted-by":"crossref","first-page":"R231","DOI":"10.1530\/EJE-17-0947","article-title":"Pitfalls on the replacement therapy for primary and central hypothyroidism in adults","volume":"178","author":"de Carvalho","year":"2018","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"R19-20230817","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1210\/jc.2012-2180","article-title":"Persistent subclinical hypothyroidism and cardiovascular risk in the elderly: the cardiovascular health study","volume":"98","author":"Hyland","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"R20-20230817","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1370\/afm.79","article-title":"Subclinical hypothyroidism and the risk of hypercholesterolemia","volume":"2","author":"Hueston","year":"2004","journal-title":"Ann Fam Med"},{"issue":"49","key":"R21-20230817","doi-asserted-by":"crossref","first-page":"e2186","DOI":"10.1097\/MD.0000000000002186","article-title":"Gender and age impact on the association between thyroid-stimulating hormone and serum lipids","volume":"94","author":"Meng","year":"2015","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"R22-20230817","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1089\/thy.2014.0219","article-title":"Subclinical hypothyroidism might worsen the effects of aging on serum lipid profiles: a population-based case-control study","volume":"25","author":"Zhao","year":"2015","journal-title":"Thyroid"},{"issue":"4","key":"R23-20230817","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.amjmed.2015.11.027","article-title":"Subclinical thyroid disease and mortality in the elderly: a retrospective cohort study","volume":"129","author":"Grossman","year":"2016","journal-title":"Am J Med"},{"issue":"9","key":"R24-20230817","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1089\/thy.2017.0414","article-title":"Subclinical hypothyroidism and the risk of cardiovascular disease and all-cause mortality: a meta-analysis of prospective cohort studies","volume":"28","author":"Moon","year":"2018","journal-title":"Thyroid"},{"issue":"12","key":"R26-20230817","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1089\/thy.2014.0028","article-title":"Guidelines for the treatment of hypothyroidism","volume":"24","author":"Jonklaas","year":"2014","journal-title":"Thyroid"},{"issue":"6","key":"R27-20230817","doi-asserted-by":"crossref","first-page":"e0156925","DOI":"10.1371\/journal.pone.0156925","article-title":"Disease-specific as well as generic quality of life is widely impacted in autoimmune hypothyroidism and improves during the first six months of levothyroxine therapy","volume":"11","author":"Winther","year":"2016","journal-title":"PLoS One"},{"issue":"26","key":"R28-20230817","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1056\/NEJMoa1603825","article-title":"Thyroid hormone therapy for older adults with subclinical hypothyroidism","volume":"376","author":"Stott","year":"2017","journal-title":"N Engl J Med"},{"issue":"8","key":"R29-20230817","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.1210\/jc.2018-00279","article-title":"Impact of thyroid hormone therapy on atherosclerosis in the elderly with subclinical hypothyroidism: a randomized trial","volume":"103","author":"Blum","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"R30-20230817","doi-asserted-by":"crossref","first-page":"e016053","DOI":"10.1136\/bmjopen-2017-016053","article-title":"Effect of levothyroxine on the progression of carotid intima-media thickness in subclinical hypothyroidism patients: a meta-analysis","volume":"7","author":"Zhao","year":"2017","journal-title":"BMJ Open"},{"issue":"3","key":"R31-20230817","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1530\/EC-17-0028","article-title":"Subclinical hypothyroidism: to treat or not to treat, that is the question! A systematic review with meta-analysis on lipid profile","volume":"6","author":"Abreu","year":"2017","journal-title":"Endocr Connect"},{"issue":"11","key":"R32-20230817","doi-asserted-by":"crossref","first-page":"4170","DOI":"10.1210\/jc.2016-2226","article-title":"Long-term outcome in levothyroxine treated patients with subclinical hypothyroidism and concomitant heart disease","volume":"101","author":"Andersen","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"R33-20230817","doi-asserted-by":"crossref","first-page":"65","DOI":"10.4065\/84.1.65","article-title":"Subclinical hypothyroidism: an update for primary care physicians","volume":"84","author":"Fatourechi","year":"2009","journal-title":"Mayo Clin Proc"}],"container-title":["JAAPA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/01.JAA.0000660120.03250.55","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T01:18:42Z","timestamp":1692321522000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/01.JAA.0000660120.03250.55"}},"subtitle":["To treat or not to treat?"],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/01.jaa.0000660120.03250.55","relation":{},"ISSN":["1547-1896"],"issn-type":[{"value":"1547-1896","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]}}}